Galectin Therapeutics shares owned by Belpointe Asset Management
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Belpointe Asset Management
from 13F filings
Historical chart of Belpointe Asset Management investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Belpointe Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Belpointe Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $442k | 106k | 4.16 |
| 2023-03-31 | $2.2k | 1.1k | 2.10 |
| 2022-12-31 | $1.2k | 1.1k | 1.13 |
| 2019-06-30 | $121k | 29k | 4.14 |
| 2019-03-31 | $138k | 27k | 5.11 |
| 2018-09-30 | $187k | 31k | 6.01 |
| 2018-06-30 | $277k | 44k | 6.36 |
More positions owned by Belpointe Asset Management
View all positions for Belpointe Asset Management